Header Logo

Connection

MICHAEL E RYTTING to Maximum Tolerated Dose

Back to Details
This is a "connection" page, showing publications MICHAEL E RYTTING has written about Maximum Tolerated Dose.
MICHAEL E RYTTING
Connection Strength
0.016
Maximum Tolerated Dose
  1. A multi-center phase I study of clofarabine, etoposide and cyclophosphamide in combination in pediatric patients with refractory or relapsed acute leukemia. Leukemia. 2009 Dec; 23(12):2259-64.
    View in: PubMed
    Score: 0.016
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.